{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:57:55Z","timestamp":1780387075694,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00417-022-05922-0","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T02:02:51Z","timestamp":1670378571000},"page":"1545-1552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Simultaneous intravitreal aflibercept and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy"],"prefix":"10.1007","volume":"261","author":[{"given":"Taku","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-5408","authenticated-orcid":false,"given":"Chikako","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Sayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Sakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"5922_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199001010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retin 10:1\u20138. https:\/\/doi.org\/10.1097\/00006982-199001010-00001","journal-title":"Retin"},{"key":"5922_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P et al (2018) Polypoidal choroidal vasculopathy definition, pathogenesis, diagnosis, and management. Ophthalmology 125:708\u2013724. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.019","journal-title":"Ophthalmology"},{"key":"5922_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","volume":"144","author":"I Maruko","year":"2007","unstructured":"Maruko I, Iida T, Saito M et al (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15-22.e2. https:\/\/doi.org\/10.1016\/j.ajo.2007.03.047","journal-title":"Am J Ophthalmol"},{"key":"5922_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajo.2014.05.004","volume":"158","author":"G Coscas","year":"2014","unstructured":"Coscas G, Yamashiro K, Coscas F et al (2014) Comparison of exudative age-related macular degeneration subtypes in Japanese and French patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol 158:309-318.e2. https:\/\/doi.org\/10.1016\/j.ajo.2014.05.004","journal-title":"Am J Ophthalmol"},{"key":"5922_CR5","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.ophtha.2014.06.016","volume":"121","author":"Y Li","year":"2014","unstructured":"Li Y, You QS, Wei WB et al (2014) Polypoidal choroidal vasculopathy in adult Chinese: the Beijing eye study. Ophthalmol 121:2290\u20132291. https:\/\/doi.org\/10.1016\/j.ophtha.2014.06.016","journal-title":"Ophthalmol"},{"key":"5922_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","volume":"49","author":"AP Ciardella","year":"2004","unstructured":"Ciardella AP, Donsoff IM, Huang SJ et al (2004) Polypoidal choroidal vasculopathy. Surv Ophthalmol 49:25\u201337. https:\/\/doi.org\/10.1016\/j.survophthal.2003.10.007","journal-title":"Surv Ophthalmol"},{"key":"5922_CR7","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","volume":"121","author":"K Sho","year":"2003","unstructured":"Sho K, Takahashi K, Yamada H et al (2003) Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol-chic 121:1392\u20131396. https:\/\/doi.org\/10.1001\/archopht.121.10.1392","journal-title":"Arch Ophthalmol-chic"},{"key":"5922_CR8","doi-asserted-by":"publisher","first-page":"e706","DOI":"10.1111\/aos.14676","volume":"99","author":"SC Cho","year":"2021","unstructured":"Cho SC, Cho J, Park KH, Woo SJ (2021) Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration. Acta Ophthalmol 99:e706\u2013e714. https:\/\/doi.org\/10.1111\/aos.14676","journal-title":"Acta Ophthalmol"},{"key":"5922_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","volume":"169","author":"JH Cho","year":"2016","unstructured":"Cho JH, Ryoo N-K, Cho KH et al (2016) Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy. Am J Ophthalmol 169:79\u201388. https:\/\/doi.org\/10.1016\/j.ajo.2016.06.014","journal-title":"Am J Ophthalmol"},{"key":"5922_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/opth.s55413","volume":"8","author":"M Kitahashi","year":"2014","unstructured":"Kitahashi M, Sakurai M, Yokouchi H et al (2014) Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy. Clin Ophthalmol 8:485\u2013492. https:\/\/doi.org\/10.2147\/opth.s55413","journal-title":"Clin Ophthalmol"},{"key":"5922_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/ceo.13198","volume":"46","author":"HG Kang","year":"2018","unstructured":"Kang HG, Kang H, Byeon SH et al (2018) Long-term visual outcomes for treatment of submacular haemorrhage secondary to polypoidal choroidal vasculopathy. Clin Exp Ophthalmol 46:916\u2013925. https:\/\/doi.org\/10.1111\/ceo.13198","journal-title":"Clin Exp Ophthalmol"},{"key":"5922_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10384-019-00679-2","volume":"63","author":"S Kimura","year":"2019","unstructured":"Kimura S, Morizane Y, Hosokawa MM et al (2019) Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy. Jpn J Ophthalmol 63:382\u2013388. https:\/\/doi.org\/10.1007\/s10384-019-00679-2","journal-title":"Jpn J Ophthalmol"},{"key":"5922_CR13","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.2147\/opth.s327138","volume":"15","author":"Y Matsuo","year":"2021","unstructured":"Matsuo Y, Haruta M, Ishibashi Y et al (2021) Visual outcomes and prognostic factors of large submacular hemorrhages secondary to polypoidal choroidal vasculopathy. Clin Ophthalmol 15:3557\u20133562. https:\/\/doi.org\/10.2147\/opth.s327138","journal-title":"Clin Ophthalmol"},{"key":"5922_CR14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.ophtha.2016.01.035","volume":"123","author":"Y Kitagawa","year":"2016","unstructured":"Kitagawa Y, Shimada H, Mori R et al (2016) Intravitreal tissue plasminogen activator, ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy. Ophthalmol 123:1278\u20131286. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.035","journal-title":"Ophthalmol"},{"key":"5922_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajo.2014.12.020","volume":"159","author":"S Kimura","year":"2015","unstructured":"Kimura S, Morizane Y, Hosokawa M et al (2015) Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator. Am J Ophthalmol 159:683-689.e1. https:\/\/doi.org\/10.1016\/j.ajo.2014.12.020","journal-title":"Am J Ophthalmol"},{"key":"5922_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ajo.2013.04.029","volume":"156","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Koh KM, Kim HS et al (2013) Anti\u2013vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol 156:524-531.e1. https:\/\/doi.org\/10.1016\/j.ajo.2013.04.029","journal-title":"Am J Ophthalmol"},{"key":"5922_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1097\/iae.0b013e31827b640c","volume":"33","author":"YJ Choi","year":"2013","unstructured":"Choi YJ, Hyun J, Choi KS et al (2013) Bullous hemorrhagic retinal detachment because of massive subretinal hemorrhage in patients with age-related macular degeneration. Retin 33:1365\u20131374. https:\/\/doi.org\/10.1097\/iae.0b013e31827b640c","journal-title":"Retin"},{"key":"5922_CR18","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.ophtha.2004.07.023","volume":"111","author":"Group SST (SST) R","year":"2004","unstructured":"Group SST (SST) R (2004) Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings SST report no. 13. Ophthalmol 111:1993-2006.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2004.07.023","journal-title":"Ophthalmol"},{"key":"5922_CR19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archopht.116.10.1326","volume":"116","author":"M Ohji","year":"1998","unstructured":"Ohji M, Saito Y, Hayashi A et al (1998) Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol-chic 116:1326\u20131332. https:\/\/doi.org\/10.1001\/archopht.116.10.1326","journal-title":"Arch Ophthalmol-chic"},{"key":"5922_CR20","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ophtha.2015.05.024","volume":"122","author":"A Yamamoto","year":"2015","unstructured":"Yamamoto A, Okada AA, Kano M et al (2015) One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy. Ophthalmol 122:1866\u20131872. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.024","journal-title":"Ophthalmol"},{"key":"5922_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ajo.2015.01.018","volume":"159","author":"A Oishi","year":"2015","unstructured":"Oishi A, Tsujikawa A, Yamashiro K et al (2015) One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome. Am J Ophthalmol 159:853-860.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.01.018","journal-title":"Am J Ophthalmol"},{"key":"5922_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00417-019-04474-0","volume":"258","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim CG, Lee DW et al (2020) Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefe\u2019s Archive Clin Exp Ophthalmol 258:107\u2013116. https:\/\/doi.org\/10.1007\/s00417-019-04474-0","journal-title":"Graefe\u2019s Archive Clin Exp Ophthalmol"},{"key":"5922_CR23","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1097\/iae.0b013e31822528c8","volume":"31","author":"T-T Wu","year":"2011","unstructured":"Wu T-T, Kung Y-H, Hong M-C (2011) Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage. Retin 31:2071\u20132077. https:\/\/doi.org\/10.1097\/iae.0b013e31822528c8","journal-title":"Retin"},{"key":"5922_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K et al (2021) Polypoidal choroidal vasculopathy consensus nomenclature and non\u2013indocyanine green angiograph diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup. Ophthalmol 128:443\u2013452. https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.006","journal-title":"Ophthalmol"},{"key":"5922_CR25","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ajo.2014.02.007","volume":"157","author":"W Chang","year":"2014","unstructured":"Chang W, Garg SJ, Maturi R et al (2014) Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol 157:1250\u20131257. https:\/\/doi.org\/10.1016\/j.ajo.2014.02.007","journal-title":"Am J Ophthalmol"},{"key":"5922_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/bjophthalmol-2011-300655","volume":"96","author":"F Treumer","year":"2012","unstructured":"Treumer F, Roider J, Hillenkamp J (2012) Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Brit J Ophthalmol 96:708. https:\/\/doi.org\/10.1136\/bjophthalmol-2011-300655","journal-title":"Brit J Ophthalmol"},{"key":"5922_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.preteyeres.2007.07.004","volume":"26","author":"X He","year":"2007","unstructured":"He X, Hahn P, Iacovelli J et al (2007) Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res 26:649\u2013673. https:\/\/doi.org\/10.1016\/j.preteyeres.2007.07.004","journal-title":"Prog Retin Eye Res"},{"key":"5922_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2021.03.012","author":"V Chaikitmongkol","year":"2021","unstructured":"Chaikitmongkol V, Upaphong P, Patikulsila D et al (2021) Timing of complete polypoidal regression following intravitreous aflibercept treatments in polypoidal choroidal vasculopathy. Ophthalmol Retin. https:\/\/doi.org\/10.1016\/j.oret.2021.03.012","journal-title":"Ophthalmol Retin"},{"issue":"3","key":"5922_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/iae.0000000000002384","volume":"40","author":"JH Cho","year":"2018","unstructured":"Cho JH, Park YJ, Cho SC et al (2018) Posttreatment polyp regression and risk of massive submacular hemorrhage in eyes with polypoidal choroidal vasculopathy. Retin 40(3):468\u2013476. https:\/\/doi.org\/10.1097\/iae.0000000000002384","journal-title":"Retin"},{"key":"5922_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/eye.2016.65","volume":"30","author":"JJ Gonz\u00e1lez-L\u00f3pez","year":"2016","unstructured":"Gonz\u00e1lez-L\u00f3pez JJ, McGowan G, Chapman E, Yorston D (2016) Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases. Eye 30:929\u2013935. https:\/\/doi.org\/10.1038\/eye.2016.65","journal-title":"Eye"},{"key":"5922_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/s0002-9394(00)00734-0","volume":"131","author":"CL Haupert","year":"2001","unstructured":"Haupert CL, McCuen BW, Jaffe GJ et al (2001) Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid\u2013gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 131:208\u2013215. https:\/\/doi.org\/10.1016\/s0002-9394(00)00734-0","journal-title":"Am J Ophthalmol"},{"key":"5922_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2147\/opth.s10060","volume":"4","author":"D Steel","year":"2010","unstructured":"Steel D (2010) Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 4:637\u2013642. https:\/\/doi.org\/10.2147\/opth.s10060","journal-title":"Clin Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05922-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05922-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05922-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T11:03:55Z","timestamp":1684494235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05922-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5922"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05922-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the (place name of institution and\/or national research committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}